X‐ray imaging serves a critical role across diverse sectors, including medical diagnostics, industrial surveillance, security, and space exploration. This study delves into the unique properties of a novel polar crystal, [FMPPA]ZnBr 4 (FMPPA = protonated 3‐fluoro‐4‐(4‐methyl‐1‐piperazinyl)aniline), characterized by a 0D metal halide structure. This crystal features [ZnBr 4 ] 2− tetrahedra and A‐site organic amine ion [FMPPA] 2+ rings. With a high photoluminescence quantum yield (≈70%) and minimal self‐absorption, [FMPPA]ZnBr 4 demonstrates exceptional scintillation performance under X‐ray excitation, producing 29300 ± 600 photons MeV −1 and achieving a low detection limit of 0.352 µGy air s −1 , surpassing conventional 3D perovskite nanocrystals. Beyond superior performance, this scintillator meets the demand for efficient X‐ray imaging light emitters. Moreover, it consistently achieves ≈12.5 lp mm −1 high‐resolution X‐ray imaging. Additionally, [FMPPA]ZnBr 4 exhibits a nonlinear optical response, surpassing the benchmark KH 2 PO 4 by 1.8 times. This investigation introduces a new structure framework, paving the way for the development of integrated optoelectronic materials with both nonlinear and linear optical properties.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: